Literature DB >> 18629679

Computational neural network analysis of the affinity of N-n-alkylnicotinium salts for the alpha4beta2* nicotinic acetylcholine receptor.

Fang Zheng1, Guangrong Zheng, A Gabriela Deaciuc, Chang-Guo Zhan, Linda P Dwoskin, Peter A Crooks.   

Abstract

Based on an 85 molecule database, linear regression with different size datasets and an artificial neural network approach have been used to build mathematical relationships to fit experimentally obtained affinity values (K(i)) of a series of mono- and bis-quaternary ammonium salts from [(3)H]nicotine binding assays using rat striatal membrane preparations. The fitted results were then used to analyze the pattern among the experimental K(i) values of a set of N-n-alkylnicotinium analogs with increasing n-alkyl chain length from 1 to 20 carbons. The affinity of these N-n-alkylnicotinium compounds was shown to parabolically vary with increasing numbers of carbon atoms in the n-alkyl chain, with a local minimum for the C(4) (n-butyl) analogue. A decrease in K(i) value between C(12) and C(13) was also observed. The statistical results for the best neural network fit of the 85 experimental K(i) values are r(2) = 0.84, rmsd = 0.39; r(cv)(2) = 0.68, and loormsd = 0.56. The generated neural network model with the 85 molecule training set may also be of value for future predictions of K(i) values for new virtual compounds, which can then be identified, subsequently synthesized, and tested experimentally.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18629679      PMCID: PMC3652805          DOI: 10.1080/14756360801945648

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  29 in total

1.  Neuroscience. What genes tell us about nicotine addiction.

Authors:  R C Hogg; D Bertrand
Journal:  Science       Date:  2004-11-05       Impact factor: 47.728

2.  Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches.

Authors:  Maykel Pérez González; Julio Caballero; Alain Tundidor-Camba; Aliuska Morales Helguera; Michael Fernández
Journal:  Bioorg Med Chem       Date:  2005-09-26       Impact factor: 3.641

3.  Interpreting computational neural network QSAR models: a measure of descriptor importance.

Authors:  Rajarshi Guha; Peter C Jurs
Journal:  J Chem Inf Model       Date:  2005 May-Jun       Impact factor: 4.956

4.  Interpreting computational neural network quantitative structure-activity relationship models: a detailed interpretation of the weights and biases.

Authors:  Rajarshi Guha; David T Stanton; Peter C Jurs
Journal:  J Chem Inf Model       Date:  2005 Jul-Aug       Impact factor: 4.956

Review 5.  Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.

Authors:  Anders A Jensen; Bente Frølund; Tommy Liljefors; Povl Krogsgaard-Larsen
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

6.  QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.

Authors:  Fang Zheng; Ersin Bayram; Sangeetha P Sumithran; Joshua T Ayers; Chang-Guo Zhan; Jeffrey D Schmitt; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2006-01-20       Impact factor: 3.641

7.  Modeling multiple species of nicotine and deschloroepibatidine interacting with alpha4beta2 nicotinic acetylcholine receptor: from microscopic binding to phenomenological binding affinity.

Authors:  Xiaoqin Huang; Fang Zheng; Peter A Crooks; Linda P Dwoskin; Chang-Guo Zhan
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

8.  CoMFA, CoMSIA, and molecular hologram QSAR studies of novel neuronal nAChRs ligands-open ring analogues of 3-pyridyl ether.

Authors:  Huabei Zhang; Hua Li; Chunping Liu
Journal:  J Chem Inf Model       Date:  2005 Mar-Apr       Impact factor: 4.956

9.  Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.

Authors:  Andrew R Tapper; Sheri L McKinney; Raad Nashmi; Johannes Schwarz; Purnima Deshpande; Cesar Labarca; Paul Whiteaker; Michael J Marks; Allan C Collins; Henry A Lester
Journal:  Science       Date:  2004-11-05       Impact factor: 47.728

10.  Steric hindrance is not required for n-alkanol cutoff in soluble proteins.

Authors:  R G Eckenhoff; J W Tanner; J S Johansson
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

View more
  5 in total

Review 1.  Nicotinic receptor antagonists as treatments for nicotine abuse.

Authors:  Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Adv Pharmacol       Date:  2014

2.  Improved Prediction of Blood-Brain Barrier Permeability Through Machine Learning with Combined Use of Molecular Property-Based Descriptors and Fingerprints.

Authors:  Yaxia Yuan; Fang Zheng; Chang-Guo Zhan
Journal:  AAPS J       Date:  2018-03-21       Impact factor: 4.009

3.  First-Principles Determination of Molecular Conformations of Indolizidine (-)-235B' in Solution.

Authors:  Fang Zheng; Linda P Dwoskin; Peter A Crooks; Chang-Guo Zhan
Journal:  Theor Chem Acc       Date:  2009-10-01       Impact factor: 1.702

4.  Modeling in vitro inhibition of butyrylcholinesterase using molecular docking, multi-linear regression and artificial neural network approaches.

Authors:  Fang Zheng; Max Zhan; Xiaoqin Huang; Mohamed Diwan M Abdul Hameed; Chang-Guo Zhan
Journal:  Bioorg Med Chem       Date:  2013-11-08       Impact factor: 3.641

5.  QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.

Authors:  Fang Zheng; Matthew J McConnell; Chang-Guo Zhan; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2009-05-08       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.